Crown Reserve Acquisition Corp. I
Definitive agreement 2026-03-30- CIK 2070887
- CRAC
- IPO 2025-11-06
- $176M trust
- 55 filings
- IPO Size
- $150M
- raised at the IPO
- Trust
- $176M
- as of 2026-06-30
- Current Status
- Definitive Agreement
- from its latest filing
- IPO Year
- 2025
- year it listed
Filings, by quarter
55 filings over 6 quarters; violet bars carry a milestone
- 25 Q2: 2 filings
- 25 Q3: 17 filings
- 25 Q4: 18 filings
- 26 Q1: 5 filings
- 26 Q2: 5 filings
- 26 Q3: 8 filings
- S-1 filed 25 Q2
- IPO 25 Q4
- Definitive agreement 26 Q1
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Crown Reserve Acquisition Corp. I is a blank-check company seeking to acquire a business. It takes a generalist approach, with particular emphasis on pharma, medical technology and medical equipment, and healthcare IT.
Investment Focus
Biopharmaceuticals, Healthcare
Key Information
As the filings state it
- IPO Date
- 2025-11-06
- PIPE
- $80M
- Jurisdiction of Incorporation
- Cayman Islands
- SIC
- 6770
- Merger Target
- Carvix, Inc.
- SPAC Ticker
- CRAC
Stock Performance
CRACUTrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2025-11-07 | $10.04 | |
| Current Price | 2026-10-16 | $10.33 | +3% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team has experience as executives, entrepreneurs, investors and advisors. CEO Prashant Patel is a pharmacist and healthcare entrepreneur with prior SPAC advisory experience; CFO Eric Sherb brings accounting, auditing, M&A, IPO and SEC reporting experience. Its director nominees have experience in healthcare, pharmaceuticals, energy, technology, finance and SPAC boards.